Ocuphire Pharma Inc (OCUP)
2.01
+0.02
(+1.00%)
USD |
NASDAQ |
May 06, 16:00
2.02
+0.01
(+0.50%)
After-Hours: 20:00
Ocuphire Pharma Price to Book Value: 0.9994 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 0.9994 |
| May 03, 2024 | 0.9894 |
| May 02, 2024 | 0.9198 |
| May 01, 2024 | 0.8154 |
| April 30, 2024 | 0.7881 |
| April 29, 2024 | 0.8204 |
| April 26, 2024 | 0.8005 |
| April 25, 2024 | 0.7632 |
| April 24, 2024 | 0.7607 |
| April 23, 2024 | 0.7657 |
| April 22, 2024 | 0.7508 |
| April 19, 2024 | 0.8229 |
| April 18, 2024 | 0.8303 |
| April 17, 2024 | 0.8651 |
| April 16, 2024 | 0.8651 |
| April 15, 2024 | 0.8751 |
| April 12, 2024 | 0.9149 |
| April 11, 2024 | 0.89 |
| April 10, 2024 | 0.9248 |
| April 09, 2024 | 0.9248 |
| April 08, 2024 | 0.9099 |
| April 05, 2024 | 0.9497 |
| April 04, 2024 | 0.9347 |
| April 03, 2024 | 0.9646 |
| April 02, 2024 | 1.084 |
| Date | Value |
|---|---|
| April 01, 2024 | 1.109 |
| March 28, 2024 | 0.9994 |
| March 27, 2024 | 1.004 |
| March 26, 2024 | 1.009 |
| March 25, 2024 | 0.9745 |
| March 22, 2024 | 1.009 |
| March 21, 2024 | 1.039 |
| March 20, 2024 | 0.9845 |
| March 19, 2024 | 0.9497 |
| March 18, 2024 | 0.9596 |
| March 15, 2024 | 0.9447 |
| March 14, 2024 | 0.9397 |
| March 13, 2024 | 1.019 |
| March 12, 2024 | 1.064 |
| March 11, 2024 | 1.039 |
| March 08, 2024 | 0.9894 |
| March 07, 2024 | 1.183 |
| March 06, 2024 | 1.203 |
| March 05, 2024 | 1.208 |
| March 04, 2024 | 1.191 |
| March 01, 2024 | 1.220 |
| February 29, 2024 | 1.222 |
| February 28, 2024 | 1.249 |
| February 27, 2024 | 1.273 |
| February 26, 2024 | 1.220 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7508
Minimum
Apr 22 2024
9.114
Maximum
Jun 10 2021
2.885
Average
2.680
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.008 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.1856 |
| Oragenics Inc | 3.072 |
Price to Book Value Related Metrics
| PS Ratio | 2.303 |
| Price | 2.01 |
| Earnings Yield | -23.88% |
| Market Cap | 49.87M |